Aztreonam
Active substance: aztreonam
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · AZTREONAM 2 g/1
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- AZTREONAM · 2 g/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 15 |
|
| EU 1 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-4cc4-782b-8f3e-5ee312546231,01a120c3-8e40-7f65-8908-094a57bb5dac,01a120c3-b55f-76aa-adbb-ad05d131e744,01a120c3-bb20-7752-8bd7-be9801f7feff,01a120c3-c371-7ac7-921c-84092251d568;count=11 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8f75-7aad-a457-dbee650b3969,01a12091-7260-766d-aa6c-b704bf79cd07,01a12092-12a2-76fd-9e30-fc1772079635,01a12093-914a-71f5-a053-59bdf7468b14,01a12095-8111-7080-929c-3656a86db1ff;count=8 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 63323-402
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS
- product · openFDA NDC · 63323-402 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63323-402 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63323-402 · Verified 2026-10-09 · open in source